Caris Life Sciences Eyes $5B Valuation with $423M IPO — Precision Oncology Goes Public with 50% Revenue Growth and 6.5M-Test Data Edge

IPO Details 🎯 Purpose: Raise approximately $423.5 million (23.5 million shares at $16–18) to expand precision oncology labs, invest in AI and R&D, and support commercial scale-up. This is clearly a growth-focused IPO. Placement...